Source study found
Story checked
Losing the Same Weight Didn’t Produce the Same Health Benefits (opens in a new tab)
scitechdaily.com · 2026-09-27
Short answer
MixedMixed.
One claim goes further than the study. 3 other points were not covered by the paper.
- 3 supported
- 1 overstated
- 3 not covered
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Losing the Same Weight Didn’t Produce the Same Health Benefits
scitechdaily.com · 2026-09-27
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Mixed
One claim overstates the study. Three of seven check out. Three claims the study doesn't address.
- 3 supported
- 1 overstated
- 3 not covered
The source study
Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial
Evidence layer
Claim by claim
Each claim gets a verdict. Expand it to see the evidence directly below.
Reading mode
Scan verdicts. Open evidence only when needed.
Browse by verdict
7 claims in this storyShowing all 7 claimsChoose a verdict to focus the list.
Claim 1 of 7OverstatedAmong several diets tested in a clinical trial, a ketogenic diet produced the greatest improvements in liver and metabolic health.View evidenceHide evidence
Why this verdict
The abstract supports that the very-low-carbohydrate ketogenic diet produced greater improvements in hepatic insulin sensitivity, intrahepatic triglyceride, de novo lipogenesis, HbA1c, and 24-hour glucose/insulin than the other diets. But the headline wording broadly says the ketogenic diet produced the greatest improvements in 'liver and metabolic health,' which outruns the more specific evidence: muscle insulin sensitivity improved similarly across all groups, and LDL-cholesterol, apolipoprotein B, and 24-hour triglycerides did not differ among groups. The body is more specific than the headline.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Study evidence
Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean or very-low-fat groups (p < 0.001).two-to-three-fold greater (p < 0.001)
“...caused a two-to-three-fold greater increase in hepatic insulin sensitivity in the very-low-carbohydrate group than the other groups (p < 0.001).”
Claim 2 of 7Not coveredThe study included 55 adults with obesity who also had prediabetes and excess fat in the liver, and it compared a ketogenic diet with a Mediterranean diet and a high-carbohydrate, low-fat, plant-forward diet.View evidenceHide evidence
As stated55 adults
Why this verdict
The abstract supports the trial design, population characteristics, and diet comparisons, but the supplied abstract-level profile does not report the sample size of 55 adults. That numerical detail cannot be verified at the requested abstract evidence depth.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Claim 3 of 7Not coveredAfter five months, liver fat had fallen by 67% in the ketogenic group, compared with 45% in each of the other two groups.View evidenceHide evidence
As stated67% vs 45% vs 45%
Why this verdict
The abstract supports the direction of the finding that intrahepatic triglyceride content decreased most in the very-low-carbohydrate group, but it does not provide the five-month duration or the exact 67% versus 45% versus 45% liver-fat reductions. These quantitative details are not verifiable from the abstract-level profile.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Study evidence
Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean or very-low-fat groups (p < 0.001).two-to-three-fold greater (p < 0.001)
“...caused a two-to-three-fold greater increase in hepatic insulin sensitivity in the very-low-carbohydrate group than the other groups (p < 0.001).”
Claim 4 of 7Not coveredBlood glucose measured over 24 hours fell 20% from baseline in the ketogenic group, compared with 8% in each of the other groups, and half of the ketogenic group reversed prediabetes during the study.View evidenceHide evidence
As stated20% vs 8% vs 8%; half reversed prediabetes
Why this verdict
The abstract supports that 24-hour serial plasma glucose and insulin decreased most in the very-low-carbohydrate group, but it does not report the exact 20% versus 8% versus 8% changes, nor does it mention that half of the ketogenic group reversed prediabetes. Those details cannot be verified at abstract depth.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Claim 5 of 7SupportedIn a randomized clinical trial, three very different diets helped adults with obesity lose about 10% of their starting weight, but the ketogenic diet produced larger improvements in liver fat, liver insulin sensitivity, and blood sugar control.View evidenceHide evidence
As statedabout 10% of starting weight
Why this verdict
The abstract describes a randomized clinical trial of very-low-carbohydrate ketogenic, Mediterranean, and very-low-fat plant-forward diets inducing moderate, approximately 10% weight loss in adults with metabolically unhealthy obesity, defined as prediabetes and hepatic steatosis. It reports that hepatic insulin sensitivity improved two- to three-fold more in the very-low-carbohydrate group and that intrahepatic triglyceride content, HbA1c, and 24-hour glucose/insulin decreased most in that group.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Study evidence
Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean or very-low-fat groups (p < 0.001).two-to-three-fold greater (p < 0.001)
“...caused a two-to-three-fold greater increase in hepatic insulin sensitivity in the very-low-carbohydrate group than the other groups (p < 0.001).”
Claim 6 of 7SupportedAll three diets improved metabolic health, but the ketogenic diet provided additional improvements in several measures related to the liver and blood sugar.View evidenceHide evidence
Why this verdict
The abstract reports that weight loss increased muscle insulin sensitivity by about 50% in all groups and that the very-low-carbohydrate group had additional greater improvements in hepatic insulin sensitivity, intrahepatic triglyceride, hepatic de novo lipogenesis, HbA1c, and 24-hour glucose/insulin. The wording is broad, but the claim specifies liver and blood-sugar-related measures, which matches the abstract evidence.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Study evidence
Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean or very-low-fat groups (p < 0.001).two-to-three-fold greater (p < 0.001)
“...caused a two-to-three-fold greater increase in hepatic insulin sensitivity in the very-low-carbohydrate group than the other groups (p < 0.001).”
Claim 7 of 7SupportedThe article says muscle insulin sensitivity improved by roughly 50% across all three diets, suggesting weight loss itself was the main factor for that outcome.View evidenceHide evidence
As statedroughly 50%
Why this verdict
The abstract explicitly states that weight loss increased muscle insulin sensitivity by approximately 50% in all groups. Because the diets produced similar approximately 10% weight loss while muscle insulin sensitivity improved similarly across arms, the story’s inference that weight loss itself was the main factor for that outcome is consistent with the abstract framing.
Study evidence
Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
Context layer
What the story left out
Important study details the story did not include.
The abstract reports no between-group differences in LDL-cholesterol, apolipoprotein B, or 24-hour plasma triglyceride concentrations.
This is a material counterbalance to broad claims about superior metabolic health from the ketogenic diet. The story presentation does not mention that key lipid and lipoprotein risk markers did not differ among diets.
From Randomized clinical trial, three-arm dietary intervention; Randomized clinical trial (three diet arms; matched ~10% weig
At abstract depth, several methodological details are unavailable, including specific measurement methods, sample sizes per arm or endpoint, intervention duration, adherence metrics, and randomization/allocation details.
The story presents detailed numerical claims and a causal framing without noting these abstract-level limitations. Some limitations may be addressed in the full paper, but they are not verifiable from the supplied abstract profile.
From Randomized clinical trial, three-arm dietary intervention; randomized clinical trial, three diet arms; matched ~10% weig
At abstract depth, exact quantitative magnitudes for liver-fat reduction, 24-hour glucose reduction, and prediabetes reversal are not provided.
The story reports exact values for these outcomes, but the supplied paper profile only supports qualitative direction for intrahepatic triglyceride and glycemic outcomes and does not mention prediabetes reversal.
From Randomized clinical trial, three-arm dietary intervention; randomized clinical trial, three diet arms; matched ~10% weig
6 things the story did carry across
- The paper is a randomized clinical trial comparing very-low-carbohydrate ketogenic, Mediterranean, and very-low-fat plant-forward diets in adults with metabolically unhealthy obesity, prediabetes, and hepatic steatosis.
- The diets were evaluated in the context of similar moderate weight loss of about 10%, not as unrestricted diet-composition changes independent of weight loss.
- The very-low-carbohydrate ketogenic diet produced greater improvements in hepatic metabolic function, including hepatic insulin sensitivity, intrahepatic triglyceride, and de novo lipogenesis, than the other diet groups.
- Glycemic measures, including HbA1c and 24-hour serial plasma glucose and insulin, decreased most in the very-low-carbohydrate group.
- Muscle insulin sensitivity improved by approximately 50% in all groups, indicating an outcome where diet composition did not distinguish the groups.
- The findings apply to adults with metabolically unhealthy obesity, prediabetes, and hepatic steatosis, so generalization beyond that population is limited.
Study layer
Study at a glance
Scan the study first. Expand only the parts you want to inspect.
Pieces of work
3
Evidence read
study summary
Lead result
human in vivo
1Lead resulthuman in vivoTest whether diet macronutrient composition (very-low-carbohydrate ketogenic vs Mediterranean vs very-low-fat plant-forward) differentially affects cardiometabolic outcomes when ~10% weight loss is achieved in adults with metabolically unhealthy obesity (prediabetes and hepatic steatosis).Randomized clinical trial, three-arm dietary interventionExpandCollapse
In plain English
Randomized clinical trial in adults with metabolically unhealthy obesity (prediabetes and hepatic steatosis) comparing three diets (very-low-carbohydrate ketogenic, Mediterranean, and very-low-fat plant-forward) that achieved similar moderate (~10%) weight loss; metabolic outcomes (muscle and hepatic insulin sensitivity, intrahepatic triglyceride, hepatic de novo lipogenesis, glycemic measures, and blood lipids) were compared across diet arms. The very-low-carbohydrate diet produced larger improvements in hepatic insulin sensitivity and several hepatic/glycemic outcomes, while muscle insulin sensitivity improved similarly across groups and LDL-C, apolipoprotein B, and 24-h triglycerides did not differ between diets.
Key findings
- Muscle insulin sensitivity increased by approximately 50% in all diet groups.≈50% increase (all groups)
- Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean and very-low-fat groups (p < 0.001).2–3-fold greater increase vs other groups; p < 0.001
“Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial”
What this piece can’t prove
- Population described is adults with metabolically unhealthy obesity (prediabetes and hepatic steatosis); findings may not generalize beyond this population (implicit from study population description).
2 further details could not be confirmed from the summary.
2human in vivoQuantify and compare changes in hepatic metabolic function with weight loss across diets (hepatic insulin sensitivity, intrahepatic triglyceride, de novo lipogenesis), emphasizing whether very-low-carbohydrate diet yields greater hepatic benefits.randomized clinical trial, three diet arms; matched ~10% weight loss targetExpandCollapse
In plain English
Abstract of a randomized clinical trial in people with metabolically unhealthy obesity reports that ~10% weight loss produced greater improvements in hepatic metabolic function (hepatic insulin sensitivity, intrahepatic triglyceride content, and hepatic de novo lipogenesis) for a very-low-carbohydrate ketogenic diet than for Mediterranean or very-low-fat plant-forward diets.
Key findings
- Hepatic insulin sensitivity increased two-to-three-fold more in the very-low-carbohydrate group than in the Mediterranean or very-low-fat groups (p < 0.001).two-to-three-fold greater (p < 0.001)
- Intrahepatic triglyceride content decreased most in the very-low-carbohydrate group compared with the other diet groups.
“...caused a two-to-three-fold greater increase in hepatic insulin sensitivity in the very-low-carbohydrate group than the other groups (p < 0.001).”
What this piece can’t prove
4 further details could not be confirmed from the summary.
3human in vivoAssess whether lipid/lipoprotein risk markers differ by diet after matched weight loss (LDL-C, apolipoprotein B, 24-hour triglycerides).Randomized clinical trial (three diet arms; matched ~10% weight loss)ExpandCollapse
In plain English
In this randomized clinical trial of three diets producing matched ~10% weight loss in people with metabolically unhealthy obesity, the abstract reports no between-group differences for LDL-cholesterol, apolipoprotein B, or 24-hour plasma triglyceride concentrations.
Key findings
- After matched ~10% weight loss, the study reports no between-group differences in LDL-cholesterol, apolipoprotein B, or 24-hour plasma triglyceride concentrations across the three diet arms.
“There were no differences among groups in LDL-cholesterol, apolipoprotein B, or 24-h plasma triglyceride concentrations.”
What this piece can’t prove
2 further details could not be confirmed from the summary.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial
Cell metabolism · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Europe PMC, Crossref · 36 candidate papers
Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial
Cell Metabolism · 2026 · PubMed, Europe PMC, Crossref
Harnessing PPAR pharmacology through dual incretin-directed delivery
Cell Metabolism · 2026 · Crossref
Hyperpolarization of [1-13C]Ketoisocaproate-d2 by Reversible Exchange with Parahydrogen Enables Profiling of Branched-Chain-Amino-Acid Metabolism in Cellulo and in Vivo.
2026 · Europe PMC
Author response for "Deep Profiling Reveals Coordinated Remodeling of Ganglioside Metabolism in MCF-7 Breast Cancer Cell Line"
2026 · Crossref
Skeletal muscle proteomics links mitochondrial abundance with peak fat oxidation in physically active young males.
2026 · Europe PMC
Attention-Driven Rendering and Interface Adaptation Using Eye-Tracking Data
Journal of Science & Technology · 2026 · Crossref
And 30 more candidates considered.